Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coated Nifedipine Suppository for Anal Fissure
NCT02023047Phase 2Terminated
- Sponsor
- RDD Pharma
- Start
- Mar 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of nifedipine in anal fissure (2 arms), sponsored by RDD Pharma. Primary endpoint: Anal fissure pain as measured by Visual Analog Score at 8 weeks. Started Mar 2014; status: terminated.
02
Drugs
nifedipine
03
Conditions
anal fissure
Beyond the preview
Go deeper on NCT02023047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02023047.